GCVI Summit 2018
Skip Content

13 September 2017

23andMe cracks the code to raise $250m

The genetics services company, which is backed by Alphabet, Illumina, WuXi PharmaTech and Johnson and Johnson, has now raised more than $490m altogether.

Author: Robert Lavine, News Editor

23andMe, the US-based genetics services provider backed by corporate investors including internet and technology conglomerate Alphabet, secured $250m yesterday in a round led by venture capital firm Sequoia Capital.